Anika Therapeutics, Inc. (ANIK)
10.63
-0.07
(-0.65%)
USD |
NASDAQ |
Feb 20, 16:00
10.62
-0.01
(-0.09%)
After-Hours: 20:00
Anika Therapeutics EPS Diluted (Quarterly) : -0.1615 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.175M |
| Revenue (Quarterly) | 27.82M |
| Total Expenses (Quarterly) | 30.99M |
| Enterprise Value | 119.81M |
| Gross Profit Margin (Quarterly) | 56.02% |
| Profit Margin (Quarterly) | -11.41% |
| Earnings Yield | -21.44% |
| Normalized Earnings Yield | -21.44 |